Thrivent Financial for Lutherans Portfolio holdings
AUM
$45.7B
1-Year Return
20.42%
This Quarter Return
+2.4%
1 Year Return
+20.42%
3 Year Return
+83.29%
5 Year Return
+151.37%
10 Year Return
+389.71%
AUM
$51.6B
AUM Growth
-$1.03B
(-2%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-2.57%
Top 10 Holdings %
Top 10 Hldgs %
17.59%
Holding
2,634
New
128
Increased
809
Reduced
1,536
Closed
86
Top Buys
| 1 |
Old Dominion Freight Line
ODFL
|
+$101M |
| 2 |
Nike
NKE
|
+$99.4M |
| 3 |
UnitedHealth
UNH
|
+$98.4M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$97.2M |
| 5 |
Broadcom
AVGO
|
+$91.2M |
Top Sells
| 1 |
Walmart
WMT
|
+$155M |
| 2 |
Option Care Health
OPCH
|
+$134M |
| 3 |
Advanced Drainage Systems
WMS
|
+$133M |
| 4 |
NOV
NOV
|
+$104M |
| 5 |
Halliburton
HAL
|
+$102M |
Sector Composition
| 1 | Technology | 20.47% |
| 2 | Financials | 11.83% |
| 3 | Consumer Discretionary | 10.57% |
| 4 | Industrials | 10.16% |
| 5 | Healthcare | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Frontier Communications
FYBR
$9.38B
| $1.81M | ﹤0.01% |
52,147
+178
| +0.3% | +$6.18K |
|
1427
Regions Financial
RF
$24.1B
| $1.81M | ﹤0.01% |
76,130
-3,323
| -4% | -$79K |
|
1428
Catalyst Pharmaceutical
CPRX
$2.48B
| $1.81M | ﹤0.01% |
86,660
-952
| -1% | -$19.9K |
|
1429
NNN REIT
NNN
$8.17B
| $1.8M | ﹤0.01% |
44,124
-42,617
| -49% | -$1.74M |
|
1430
Seacoast Banking Corp of Florida
SBCF
$2.72B
| $1.8M | ﹤0.01% |
65,452
-933
| -1% | -$25.7K |
|
1431
Abercrombie & Fitch
ANF
$4.44B
| $1.8M | ﹤0.01% |
12,019
+13
| +0.1% | +$1.94K |
|
1432
Light & Wonder
LNW
$7.42B
| $1.8M | ﹤0.01% |
20,778
-66
| -0.3% | -$5.7K |
|
1433
Ziff Davis
ZD
$1.54B
| $1.8M | ﹤0.01% |
33,037
-2,098
| -6% | -$114K |
|
1434
Yum! Brands
YUM
$41.4B
| $1.79M | ﹤0.01% |
13,316
+316
| +2% | +$42.5K |
|
1435
iShares S&P Small-Cap 600 Growth ETF
IJT
$6.35B
| $1.79M | ﹤0.01% |
12,728
+3,324
| +35% | +$466K |
|
1436
Stepan Co
SCL
$1.12B
| $1.79M | ﹤0.01% |
27,601
-4,797
| -15% | -$310K |
|
1437
1st Source
SRCE
$1.58B
| $1.79M | ﹤0.01% |
30,574
-2,653
| -8% | -$155K |
|
1438
Insulet
PODD
$23.8B
| $1.78M | ﹤0.01% |
6,820
+3,940
| +137% | +$1.03M |
|
1439
Protagonist Therapeutics
PTGX
$3.71B
| $1.78M | ﹤0.01% |
46,066
-191
| -0.4% | -$7.37K |
|
1440
First American
FAF
$6.93B
| $1.77M | ﹤0.01% |
28,375
+4,204
| +17% | +$263K |
|
1441
Murphy Oil
MUR
$3.69B
| $1.77M | ﹤0.01% |
58,517
-448
| -0.8% | -$13.6K |
|
1442
Bruker
BRKR
$4.87B
| $1.77M | ﹤0.01% |
30,200
-60,084
| -67% | -$3.52M |
|
1443
Pricesmart
PSMT
$3.63B
| $1.77M | ﹤0.01% |
19,194
-6,789
| -26% | -$626K |
|
1444
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.29B
| $1.77M | ﹤0.01% |
40,920
+22,719
| +125% | +$982K |
|
1445
Jazz Pharmaceuticals
JAZZ
$7.79B
| $1.77M | ﹤0.01% |
14,336
-283
| -2% | -$34.8K |
|
1446
Energizer
ENR
$1.99B
| $1.76M | ﹤0.01% |
50,500
-806
| -2% | -$28.1K |
|
1447
Azenta
AZTA
$1.43B
| $1.76M | ﹤0.01% |
35,223
+23,731
| +207% | +$1.19M |
|
1448
Federated Hermes US Strategic Dividend ETF
FDV
$454M
| $1.76M | ﹤0.01% |
+62,322
| New | +$1.76M |
|
1449
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$989M
| $1.76M | ﹤0.01% |
18,377
-77
| -0.4% | -$7.36K |
|
1450
Avantis US Equity ETF
AVUS
$9.64B
| $1.76M | ﹤0.01% |
17,441
-4,226
| -20% | -$425K |
|